drugset / Trial / NCT05630846
A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
RandomizedParallel-groupDouble-blindPrevention
Summary
The main purpose of this study is to assess immune response and safety of various potencies of a measles, mumps, rubella, and varicella (MMRVNS) vaccines given to healthy children of 4 to 6 years of age.
Timeline
- Start
- 2022-12-14
- Primary completion
- 2024-06-07
- Completion
- 2024-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | M(L)M(L)R(L)V(L)NS | Unknown | — | Subcutaneous |
| Subject | MM(H)RVNS | Unknown | — | Subcutaneous |
| Subject | MMRV(H)NS | Unknown | — | Subcutaneous |
| Comparator | ProQuad | Vaccine | — | Subcutaneous |